SILVER DE[au] - Search Results

Year	Number of Results
1971	1
1972	1
1975	1
1979	2
1980	1
1994	1
1998	1
2004	1
2007	1
2008	1
2010	2
2011	2
2015	1
2016	1
2017	1
2022	0

1

Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy.

Espay AJ, Pagan FL, Walter BL, Morgan JC, Elmer LW, Waters CH, Agarwal P, Dhall R, Ondo WG, Klos KJ, Silver DE. Espay AJ, et al. Among authors: silver de. Neurol Clin Pract. 2017 Feb;7(1):86-93. doi: 10.1212/CPJ.0000000000000316. Neurol Clin Pract. 2017. PMID: 28243505 Free PMC article. Review.

2

Initiating therapy for Parkinson's disease.

Silver DE, Ruggieri S. Silver DE, et al. Neurology. 1998 Jun;50(6 Suppl 6):S18-22; discussion S44-8. doi: 10.1212/wnl.50.6_suppl_6.s18. Neurology. 1998. PMID: 9633682 Review.

3

Determining the efficacy of rasagiline in reducing bradykinesia among Parkinson's disease patients: a review.

Silver DE, Buck PO. Silver DE, et al. Int J Neurosci. 2011 Sep;121(9):485-9. doi: 10.3109/00207454.2011.582240. Epub 2011 Jun 15. Int J Neurosci. 2011. PMID: 21671840 Review.

4

Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo).

Silver DE. Silver DE. Expert Rev Neurother. 2004 Jul;4(4):589-99. doi: 10.1586/14737175.4.4.589. Expert Rev Neurother. 2004. PMID: 15853578 Review.

5

Early, nondisabling Parkinson's disease: weighing the options for initial therapy.

Silver DE. Silver DE. Neurol Clin. 2008 Aug;26(3 Suppl):S1-13, v. doi: 10.1016/j.ncl.2008.05.004. Neurol Clin. 2008. PMID: 18774439 Review.

6

Physicians' experience with RYTARY (carbidopa and levodopa) extended-release capsules in patients who have Parkinson disease.

Silver DE, Trosch RM. Silver DE, et al. Neurology. 2016 Apr 5;86(14 Suppl 1):S25-35. doi: 10.1212/WNL.0000000000002511. Epub 2016 Apr 4. Neurology. 2016. PMID: 27044647

7

An algorithm for the management of Parkinson's disease.

Koller WC, Silver DE, Lieberman A. Koller WC, et al. Among authors: silver de. Neurology. 1994 Dec;44(12 Suppl 10):S1-52. Neurology. 1994. PMID: 7854513 Review. No abstract available.

8

Pharmacologic management of Parkinson's disease in long-term care residents: maintaining functionality to improve quality of life.

Silver DE. Silver DE. Director. 2007 Spring;15(2):20-9. Director. 2007. PMID: 19343903 Review. No abstract available.

9

Tolerability and efficacy of switching from oral selegiline to Zydis selegiline in patients with Parkinson's disease.

Ondo WG, Hunter C, Isaacson SH, Silver DE, Stewart RM, Tetrud JW, Davidson A. Ondo WG, et al. Among authors: silver de. Parkinsonism Relat Disord. 2011 Feb;17(2):117-8. doi: 10.1016/j.parkreldis.2010.10.001. Epub 2010 Nov 16. Parkinsonism Relat Disord. 2011. PMID: 21084213 Clinical Trial.

10

Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial.

Waters CH, Nausieda P, Dzyak L, Spiegel J, Rudzinska M, Silver DE, Tsurkalenko ES, Kell S, Hsu A, Khanna S, Gupta S. Waters CH, et al. Among authors: silver de. CNS Drugs. 2015 Apr;29(4):341-50. doi: 10.1007/s40263-015-0242-2. CNS Drugs. 2015. PMID: 25895021 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results